The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127155692 12715569 2 F 2016 20160914 20160906 20160921 EXP US-UCBSA-2016033926 UCB 0.00 F Y 88.00000 KG 20160921 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127155692 12715569 1 PS LACOSAMIDE. LACOSAMIDE 1 Oral 150 MG, 2X/DAY (BID) 22253 150 MG BID
127155692 12715569 2 SS LACOSAMIDE. LACOSAMIDE 1 Oral 200 MG, 2X/DAY (BID) 22253 200 MG BID
127155692 12715569 3 SS KEPPRA LEVETIRACETAM 1 Oral 1000 MG, 2X/DAY (BID) 0 1000 MG FILM-COATED TABLET BID
127155692 12715569 4 SS KEPPRA LEVETIRACETAM 1 Oral 1500 MG, 2X/DAY (BID) 0 1500 MG FILM-COATED TABLET BID
127155692 12715569 5 C Multivitamin VITAMINS 1 Oral UNK 0
127155692 12715569 6 C Magnesium MAGNESIUM 1 Oral 400 MG, UNK 0 400 MG
127155692 12715569 7 C VITAMIN B COMPLEX CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX 1 Oral UNK 0
127155692 12715569 8 C Calcium CALCIUM 1 Oral UNK 0
127155692 12715569 9 C DEXAMETHASONE. DEXAMETHASONE 1 Oral 2 MG, 2X/DAY (BID) 0 2 MG BID
127155692 12715569 10 C DILANTIN PHENYTOIN 1 Oral 100 MG, 3X/DAY (TID) 0 100 MG TID
127155692 12715569 11 C COTRIMOXAZOLE SULFAMETHOXAZOLETRIMETHOPRIM 1 Oral 800-150 MG, 3X/WEEK 0 TIW
127155692 12715569 12 C PROTONIX PANTOPRAZOLE SODIUM 1 Oral 40 MG, ONCE DAILY (QD) 0 40 MG QD
127155692 12715569 13 C LIPITOR ATORVASTATIN CALCIUM 1 Oral UNK 0
127155692 12715569 14 C Atorvastatin ATORVASTATIN 1 Oral UNK 0
127155692 12715569 15 C ASPIRIN. ASPIRIN 1 Oral 325 MG, 2X/DAY (BID) 0 325 MG BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127155692 12715569 1 Partial seizures
127155692 12715569 2 Seizure
127155692 12715569 3 Seizure
127155692 12715569 5 Supplementation therapy
127155692 12715569 6 Supplementation therapy
127155692 12715569 7 Supplementation therapy
127155692 12715569 8 Supplementation therapy
127155692 12715569 9 Brain oedema
127155692 12715569 10 Product used for unknown indication
127155692 12715569 11 Product used for unknown indication
127155692 12715569 12 Product used for unknown indication
127155692 12715569 13 Prophylaxis
127155692 12715569 14 Blood pressure measurement
127155692 12715569 15 Stent placement

Outcome of event

Event ID CASEID OUTC COD
127155692 12715569 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
127155692 12715569 Amnesia
127155692 12715569 Fall
127155692 12715569 Fatigue
127155692 12715569 Joint injury
127155692 12715569 Mental impairment
127155692 12715569 Seizure

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127155692 12715569 1 201606 201608 0
127155692 12715569 2 201608 0
127155692 12715569 9 201605 0
127155692 12715569 10 201605 0
127155692 12715569 12 201605 0
127155692 12715569 15 2015 0